Abstract
Background:
There are limited data on how sex influences the outcomes of acute myocardial infarction-cardiogenic shock (AMI-CS) in young adults.
Methods:
A retrospective cohort of AMI-CS admissions aged 18–55 years, during 2000–2017, was identified using the National Inpatient Sample. Use of coronary angiography, percutaneous coronary intervention (PCI), mechanical circulatory support (MCS) and non-cardiac interventions was identified. Outcomes of interest included in-hospital mortality, use of cardiac interventions, hospitalization costs, and length of stay.
Results:
A total 90,648 AMI-CS admissions ≤55 years of age were included, of which 26% were women. Higher rates of CS were noted in men (2.2% in 2000 to 4.8% in 2017) compared to women (2.6% in 2000 to 4.0% in 2017) (p<0.001). Compared to men, women with AMI-CS were more frequently of black race, from a lower socio-economic status, with higher comorbidity, and admitted to rural and small hospitals (all p<0.001). Women had lower rates of ST-segment elevation presentation (73.0% vs. 78.7%), acute non-cardiac organ failure, cardiac arrest (34.3% vs. 35.7%), and received less frequent coronary angiography (78.3% vs. 81.4%), early coronary angiography (49.2% vs. 54.1%), PCI (59.2% vs. 64.0%), and MCS (50.3% vs. 59.2%) (all p<0.001). Female sex was an independent predictor of in-hospital mortality (23.0% vs. 21.7%; adjusted odds ratio 1.11 [95% confidence interval 1.07–1.16]; p<0.001). Women had lower hospitalization costs (156,372±198,452 vs. 167,669±208,577; p<0.001) but comparable lengths of stay compared to men.
Conclusions:
In young AMI-CS admissions, women are treated less aggressively and experience higher in-hospital mortality than men.
Keywords: Acute myocardial infarction, cardiogenic shock, sex differences, young adults, female
Cardiogenic shock following acute myocardial infarction (AMI-CS) continues to carry a significant morbidity and mortality, despite the advances in the acute cardiovascular care.1–6 CS is the leading cause of death in patients with AMI who reach the hospital alive, with mortality rates of approximately 50%, mainly occurring within the first 48 hours on admission.7 This mortality is attributed to cardiac pump failure, leading to persistent hypotension and organ hypoperfusion and subsequent multi-organ failure.2, 3, 8–10 Prior studies have demonstrated persistent health care disparities, including sex-based disparities, in the management and outcomes of patients with AMI-CS.11, 12 Women with AMI-CS frequently receive less frequent coronary angiography, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and mechanical circulatory support (MCS) compared to their male counterparts.11, 13, 14 In spite of that, there is evidence that women might actually derive greater benefit from more aggressive, timely and appropriate cardiac interventions.4, 13–17
A majority of these studies have been conducted in older adults or all comers, and therefore younger patients are frequently under-represented.18, 19 In the modern era, with the increased prevalence of obesity and other cardiovascular co-morbidities, AMI is increasing in the younger population.14, 19, 20 There are limited data on the outcomes of AMI-CS in the young population. Whether sex disparities are pervasive in this highly selected group of patients is unclear given that younger women may exhibit fewer traditional atherosclerotic cardiovascular risk factors, higher rates of delayed reperfusion and have more frequent target lesion failure than age-matched men.18–23 Woman are also known to have less obstructive coronary artery disease as a cause for their AMI and whether, in the presence of CS, this makes a difference to outcome is unknown.14, 20
Using a nationally-representative population, we sought to determine if there are sex disparities in the clinical management and outcomes of AMI-CS in the young. We hypothesized that young women with AMI-CS would receive less frequent cardiac procedures and would have higher in-hospital mortality as compared to young men.
MATERIAL AND METHODS
The National (Nationwide) Inpatient Sample (NIS) is the largest all-payer database of hospital inpatient stays in the United States. NIS contains discharge data from a 20% stratified sample of community hospitals and is a part of the Healthcare Quality and Utilization Project (HCUP), sponsored by the Agency for Healthcare Research and Quality.24 Information regarding each discharge includes patient demographics, primary payer, hospital characteristics, principal diagnosis, up to 24 secondary diagnoses, and procedural diagnoses. The HCUP-NIS does not capture individual patients but captures all information for a given admission. Institutional Review Board approval was not needed since this database was publicly available and de-identified. These data are available to other authors via the HCUP-NIS database with the Agency for Healthcare Research and Quality.
Using the HCUP-NIS data from 2000–2017, a retrospective cohort study of admissions between the ages of 18 to 55 years, with AMI in the primary diagnosis field (International Classification of Diseases 9.0 Clinical Modification [ICD-9CM] 410.x and ICD-10CM I21.x-22.x) and a secondary diagnosis of CS (ICD-9CM 785.51, ICD-10CM R57.0) were identified. Admissions without data on sex or in-hospital mortality were excluded. The Deyo’s modification of the Charlson Comorbidity Index was used to identify the burden of co-morbid diseases (Supplementary Table 1).25 Demographic characteristics, hospital characteristics, acute organ failure, coronary angiography, PCI, MCS, and non-cardiac organ support use were identified for all admissions using previously used methodologies from our group.1–6, 8–10, 12, 26–39 Early coronary angiography was defined as that performed on hospital day zero; the hospital day the procedure was performed was used to time concomitant procedures.
The primary outcome was the in-hospital mortality in male and female AMI-CS admissions. Temporal trends of CS prevalence, in-hospital mortality and use of cardiac procedures were evaluated. Secondary outcomes included hospital length of stay, hospitalization costs, use of do-not-resuscitate (DNR) status, palliative care referral, and discharge disposition in male and female AMI-CS admissions.
Statistical Analysis
As recommended by HCUP-NIS, survey procedures using discharge weights provided with HCUP-NIS database were used to generate national estimates.40 Using the trend weights provided by the HCUP-NIS, samples from 2000–2011 were re-weighted to adjust for the 2012 HCUP-NIS re-design.40 Chi-square/one-way analysis of variance and t-tests were used to compare 2/≥2 categorical and continuous variables, respectively. Multivariable logistic regression was used to analyze trends over time (referent year 2000). Univariable analysis for trends and outcomes was performed and was represented as odds ratio (OR) with 95% confidence interval (CI). Multivariable logistic regression analysis incorporating age, sex, race, primary payer status, socio-economic stratum, hospital characteristics, comorbidities, acute organ failure, AMI-type, cardiac procedures, non-cardiac procedures, DNR status, and palliative care referral was performed for assessing temporal trends of prevalence and in-hospital mortality. For the multivariable modeling, regression analysis with purposeful selection of statistically (liberal threshold of p<0.20 in univariate analysis) and clinically relevant variables was conducted. There was a statistically significant interaction between sex and adjusted temporal trends of prevalence and in-hospital mortality (p=0.02 and p=0.04 for interaction, respectively). Multiple sub-group analyses stratifying the population by race, presence of cardiac arrest, type of AMI, receipt of PCI and MCS, were performed to confirm the results of the primary analysis. Given the large sample size, all p-values that are statistically significant may not be clinically significant.
The inherent restrictions of the HCUP-NIS database related to research design, data interpretation, and data analysis were addressed using prescribed best practices.40, 41 Pertinent considerations include not assessing individual hospital-level volumes (due to changes to sampling design detailed above), treating each entry as an ‘admission’ as opposed to individual patients, restricting the study details to inpatient factors since the HCUP-NIS does not include outpatient data, and limiting administrative codes to those previously validated and used for similar studies. Two-tailed p<0.05 was considered statistically significant. All statistical analyses were performed using SPSS v25.0 (IBM Corp, Armonk NY).
RESULTS
In the period from January 1, 2000 to December 31, 2017, there were over 11 million AMI admissions, of which 2,540,100 (23.1%) were aged 18–55 years. CS complicated 90,648 of these younger admissions (3.6%) with a comparable prevalence between men (67,004; 3.6%) and women (23,644; 3.5%) (p<0.001). The 18-year temporal trends of CS prevalence in young AMI admissions by sex are presented in Figure 1A and 1B. CS was noted in 2–5% of AMI admissions with a steady increase in trend in both sexes, though men had higher rates of CS compared to young women. Compared to men, women with AMI-CS were more often black, from a lower socio-economic status, with higher comorbidity, and were admitted more frequently to rural and small hospitals (all p<0.001) (Table 1).
Figure 1. Trends in the prevalence and in-hospital mortality in younger AMI-CS admissions stratified by sex.

A: Unadjusted temporal trends of the proportion of AMI admissions with CS stratified by sex (p<0.001 for trend over time); B: Adjusted odds ratio for admission with AMI-CS by year with 2000 as the referent; adjusted for race, comorbidity, primary payer, socio-economic status, and hospital characteristics (p<0.001 for trend over time); C: Unadjusted in-hospital mortality in AMI-CS by year of admission, stratified by sex (p<0.001 for trend over time); D: Adjusted multivariate logistic regression for in-hospital mortality temporal trends with 2000 as referent year; adjusted for race, admission year, primary payer status, socio-economic stratum, hospital characteristics, comorbidities, AMI type, acute organ failure, cardiac arrest, cardiac procedures; non-cardiac procedures; do-not-resuscitate status; palliative care referral (p<0.001 for trend over time).
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock
Table 1. Baseline characteristics of young adults with AMI-CS stratified by sex.
Represented as percentage or mean ± standard deviation.
| Characteristic | Young men (N= 67,004) |
Young women (N = 23,644) |
P | |
|---|---|---|---|---|
| Age (years) | 48.8 ± 5.6 | 48.3 ± 6.2 | <0.001 | |
| Race | ||||
| White | 58.2 | 58.4 | <0.001 | |
| Black | 7.5 | 12.0 | ||
| Others* | 34.3 | 29.6 | ||
| Weekend admission | 29.1 | 27.6 | <0.001 | |
| Primary payer | ||||
| Medicare | 10.7 | 14.9 | <0.001 | |
| Medicaid | 16.9 | 22.9 | ||
| Private | 50.9 | 46.3 | ||
| Others† | 21.6 | 15.9 | <0.001 | |
| Quartile of median household income for zip code | ||||
| 0–25th | 26.3 | 30.3 | <0.001 | |
| 26th-50th | 26.2 | 27.1 | ||
| 51st-75th | 24.6 | 23.5 | ||
| 75th-100th | 23.0 | 19.1 | ||
| Charlson Comorbidity Index | ||||
| Mean | 2.1 ± 1.7 | 2.2 ± 1.7 | <0.001 | |
| 0–3 | 84.1 | 80.3 | ||
| 4–6 | 14.1 | 18.0 | ||
| ≥ 7 | 1.8 | 1.7 | ||
| Comorbidities | ||||
| Heart failure | 37.4 | 37.9 | 0.13 | |
| CKD | 5.4 | 5.8 | 0.02 | |
| Cancer | 1.8 | 3.0 | <0.001 | |
| AIDS | 0.8 | 0.3 | <0.001 | |
| Chronic lung disease | 11.8 | 17.2 | ||
| Stroke/TIA | 3.2 | 3.5 | 0.03 | |
| Hemiplegia | 0.7 | 0.7 | 0.59 | |
| Prior CABG | 1.8 | 1.9 | 0.37 | |
| Prior pacemaker | 0.3 | 0.5 | <0.001 | |
| Prior ICD | 1.1 | 0.8 | <0.001 | |
| Atrial fibrillation | 12.8 | 9.2 | <0.001 | |
| SVT | 1.2 | 1.1 | 0.30 | |
| Hospital teaching status and location | ||||
| Rural | 4.9 | 6.0 | <0.001 | |
| Urban non-teaching | 34.5 | 34.1 | ||
| Urban teaching | 60.7 | 59.9 | ||
| Hospital bed-size | ||||
| Small | 7.4 | 7.7 | 0.08 | |
| Medium | 22.2 | 21.6 | ||
| Large | 70.4 | 70.8 | ||
| Hospital region | ||||
| Northeast | 15.3 | 15.0 | <0.001 | |
| Midwest | 23.3 | 24.6 | ||
| South | 41.5 | 43.1 | ||
| West | 20.0 | 17.3 | ||
Hispanic, Asian or Pacific Islander, Native American, Others;
Self-Pay, No Charge, Others
Abbreviations: AIDS: acquired immune deficiency syndrome; AMI: acute myocardial infarction; CABG: coronary artery bypass grafting; CKD: chronic kidney disease; CS: cardiogenic shock; ICD: implantable cardioverter defibrillator; SVT: supraventricular tachycardia; TIA: transient ischemic attack.
Women with AMI-CS had lower rates of ST-segment elevation AMI-CS presentation (73.0% vs. 78.7%), lower rates of acute non-cardiac organ failure, and lower rates of cardiac arrest (34.3% vs. 35.7%) (all p<0.001) (Table 2). Compared to men, women received less frequent coronary angiography (78.3% vs. 81.4%), early coronary angiography (49.2%vs. 54.1%), PCI (59.2% vs. 64.0%), CABG (18.3% vs. 20.1%) and MCS (50.3% vs. 59.2%) (all p<0.001). Temporal trend analysis showed persistently higher rates of coronary angiography, PCI and MCS use in men compared to women (Figure 2).
Table 2. In-hospital characteristics of young adults with AMI-CS stratified by sex.
Represented as percentage
| Characteristic | Young men (N= 67,004) |
Young women (N = 23,644) |
P | |
|---|---|---|---|---|
| Acute organ failure | ||||
| Respiratory | 42.8 | 43.7 | 0.71 | |
| Renal | 27.4 | 21.9 | <0.001 | |
| Hepatic | 10.5 | 8.8 | <0.001 | |
| Hematologic | 10.4 | 10.3 | 0.70 | |
| Neurologic | 16.6 | 16.6 | 0.98 | |
| Takotsubo cardiomyopathy | 0.1 | 0.7 | <0.001 | |
| Ischemic stroke | 2.4 | 2.6 | 0.09 | |
| Intracranial hemorrhage | 0.6 | 0.8 | 0.02 | |
| Intravascular ultrasound | 2.1 | 2.1 | 0.81 | |
| Coronary thrombectomy | 2.4 | 2.1 | 0.01 | |
| Pulmonary artery catheterization | 7.5 | 7.4 | 0.64 | |
| Mechanical circulatory support | ||||
| Total | 59.2 | 50.3 | <0.001 | |
| IABP | 54.7 | 47.0 | <0.001 | |
| pLVAD | 4.2 | 3.0 | <0.001 | |
| ECMO | 1.9 | 1.6 | <0.001 | |
| Invasive mechanical ventilation | 41.7 | 43.2 | <0.001 | |
| Non-invasive ventilation | 2.5 | 2.3 | 0.08 | |
| Hemodialysis | 2.6 | 1.8 | <0.001 | |
| Fiberoptic bronchoscopy | 3.6 | 3.0 | <0.001 | |
| Electroencephalogram | 0.7 | 0.9 | 0.002 | |
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock; ECMO: extracorporeal membrane oxygenation; IABP: intra-aortic balloon pump; NSTEMI: non-ST-segment elevation myocardial infarction; pLVAD: percutaneous left ventricular assist device; STEMI: ST-segment elevation myocardial infarction
Figure 2. Trends in the use of coronary angiography, PCI, PAC and MCS in younger AMI-CS admissions stratified by sex.

Eighteen-year trends in the use of coronary angiography (A), PCI (B), PAC (C) and MCS (D) in younger AMI-CS admissions stratified by sex; all p<0.001 for trend over time
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock; MCS: mechanical circulatory support; PAC: pulmonary artery catheterization; PCI: percutaneous coronary intervention
Compared to men, women had a higher unadjusted in-hospital mortality (23.0% vs. 21.7%, unadjusted OR 1.16 [95% CI 1.10–1.22]; p<0.001). The 15-year unadjusted and adjusted temporal trends of in-hospital mortality in AMI-CS stratified by sex are presented in Figure 1C and 1D. Despite significant decreases in in-hospital mortality over time in both men and women, after adjustment for race, admission year, primary payer status, socio-economic stratum, hospital characteristics, comorbidities, AMI type, acute organ failure, cardiac arrest, cardiac procedures; non-cardiac procedures; do-not-resuscitate status; palliative care referral, women had significantly higher in-hospital mortality than men throughout the early part of the study period. In a multivariable logistic regression for in-hospital mortality in young AMI-CS admissions, female sex was an independent predictor of higher in-hospital mortality (OR 1.11 [95% CI 1.07–1.16]; p<0.001) (Supplementary Table 2). In stratified pre-specified sub-group analyses (Figure 3), female sex was an independent predictor of higher in-hospital mortality in admissions of white race, with concomitant cardiac arrest, ST-segment elevation AMI-CS presentation and those not receiving PCI or MCS. Women had comparable rates of DNR status use, palliative care referral, and hospital length of stay to men (Table 3). However, compared to men, women had lower hospitalization costs and less frequent discharges to home (Table 3).
Figure 3. Multivariate predictors of in-hospital mortality in younger women with AMI-CS compared to younger men.

Multivariable adjusted odds ratios (95% confidence intervals)* for in-hospital mortality in the women stratified by race, presence of cardiac arrest, type of AMI, receipt of PCI and MCS; all p<0.001
*Adjusted race, year of admission, primary payer, socio-economic status, hospital location/teaching status, hospital bedsize, hospital region, comorbidity, type of AMI, acute organ failure, cardiac arrest, coronary angiography, PCI, coronary artery bypass grafting; pulmonary artery catheterization, MCS, mechanical ventilation; hemodialysis; do-not-resuscitate status; palliative care referral
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock; MCS: mechanical circulatory support; NSTEMI: non-ST-elevation myocardial infarction; PCI: percutaneous coronary intervention; STEMI: ST-elevation myocardial infarction
Table 3. Clinical outcomes of young adults with AMI-CS stratified by sex.
Represented as: Percentage or mean ± standard deviation
| Characteristic | Young men (N= 67,004) |
Young women (N = 23,644) |
P | |
|---|---|---|---|---|
| In-hospital mortality | 21.7 | 23.0 | <0.001 | |
| Length of stay (days) | 10.3 ± 12.5 | 10.6 ± 13.3 | 0.001 | |
| Hospitalization costs (USD) | 167,669 ± 208,577 | 156,372 ± 198,452 | <0.001 | |
| Do-not-resuscitate status use | 2.9 | 2.9 | 0.64 | |
| Palliative care referral | 3.1 | 3.1 | 0.85 | |
| Discharge disposition | ||||
| Home | 64.1 | 57.2 | ||
| Hospital transfer | 11.3 | 11.9 | ||
| Skilled nursing facility | 10.8 | 13.7 | ||
| Home with home health care | 12.7 | 16.4 | ||
| Against medical advice | 1.1 | 0.8 | ||
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock; USD: United States Dollars
DISCUSSION
In this study of young AMI-CS admissions, we observed that women were more likely to be black, with higher comorbidity, and have a lower frequency of non-cardiac organ failure and cardiac arrest compared to men. Younger women underwent less frequent coronary angiography, PCI and MCS utilization compared to younger men. Female sex was an independent predictor of higher in-hospital mortality, with a consistently higher temporal trend during this 18-year period. Female sex was a predictor of higher in-hospital mortality in high-risk subgroups such as those with ST-segment elevation AMI-CS presentation, with concomitant cardiac arrest, and those not receiving PCI or MCS support.
There are limited data on sex-specific outcomes in AMI-CS. Studies analyzing all patients, the majority of whom are elderly, with AMI-CS from IABP-SHOCK II (The Intraaortic Balloon Pump in Cardiogenic Shock II), SHOCK (SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK) registry, and CULPRIT-SHOCK (The Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock) trials did not show difference in mortality between women and men.21, 22, 42 These studies noted women have higher comorbidity, more frequent adverse clinical events, higher rates of mechanical complications and received guideline-directed therapies less often as in this study, but concluded that they derived similar benefits from use of revascularization and had comparable in-hospital outcomes.21–23, 42 In contrast, prior work from our group, has demonstrated that older (≥75 years) women do worse than men with AMI-CS.11
As compared to these populations, younger AMI patients are unique in their varied etiology of AMI, lower comorbidity burden, greater prevalence of high-risk lifestyle behaviors, and lower healthcare utilization.20 It is unclear if similar sex disparities are noted in younger women with AMI-CS compared to younger men. In one study of AMI patients ≤45 years, Bandyopadhyay et al. found that despite having a higher comorbidity burden, women had comparable in-hospital mortality and lower rates of CS compared to men.19 Epps et al. have noted that young women, despite having less severe disease on coronary angiography, are at higher risk for target vessel and target lesion failure.18 In the VIRGO study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients), female sex was associated with reperfusion delay in young patients with ST-segment elevation AMI.16 Taken in aggregate, these findings suggest that sex-specific disparities exist in young AMI patients. Our study adds to this literature by specifically evaluating AMI-CS admissions. We note higher in-hospital mortality in young women with AMI-CS. In addition to the potential reasons as stated above, this current analysis indicates that, a) women had a worse comorbidity profile, higher rates of prior chronic kidney disease and cancer, and greater use of invasive mechanical ventilation, all of which portent a poor prognosis and may have served as a deterrent for performance of invasive procedures (Table 1);9 b) despite an increase in the uptake of coronary angiography, early coronary angiography and PCI over time, women consistently received these therapies less frequently; c) women had a lower socio-economic status, which is associated with lower access to healthcare resources and poorer baseline management of comorbidities prior to hospitalization; d) it is conceivable that consistent with prior literature, women present with delayed and atypical symptoms and are often misdiagnosed resulting in less frequent guideline-directed care;14, 20 and e) a significant portion of young women were admitted to small and rural hospitals, which we have previously shown to be associated with worse outcomes in AMI-CS.1, 5 It is important to note that the etiology of AMI-CS in this young population could not be assessed in this study, and further details are needed to clarify the etiology given the high rates of non-plaque rupture mechanisms in this population.14, 20 Lastly, hospital-level disparities in this population are worthy of further evaluation for future studies.
In addition to poor outcomes, women typically receive less frequent cardiac procedures, including PCI, CABG, and MCS.11, 12, 33, 35, 37 The majority of these studies included older women with a few studies assessing management in younger women.43 In AMI admissions ≤45 years, women received less PCI, CABG and were less likely to undergo timely PCI within 24 hours of presentation as compared to men.19 Prior work from our group has noted younger age, male sex, lower comorbidity, and cardiac arrest to independently predicted MCS-assisted PCI in AMI-CS.33 Consistent with these data, in the current study we noted younger women to receive less frequent coronary angiography, PCI and MCS in AMI-CS. It is conceivable that lower rates of acute organ failure might explain the lower MCS use. However, prior data have shown that clinicians worry about higher complications with large-bore MCS in women due to smaller caliber of femoral vessels, lower body surface area and higher rates of bleeding.13, 14, 34 As noted in this study, females has higher rates of intracranial hemorrhages suggestive of higher rates of complications from both antiplatelet/anticoagulation therapies and MCS use.
Using the HCUP-NIS database between 2001 and 2010, Gupta et al. showed race to play a larger role in young women with AMI compared to young men.44 They noted black race to be associated with higher mortality in all-comers AMI population.44 In our prior work in older patients, we similar noted non-white race to be an independent predictor of worse outcomes in older AMI-CS admissions.11 Data from the SHOCK trial have shown no racial/ethnic differences in AMI-CS patients after adjusting for patient characteristics and use of revascularization.45 In young women ≤55 years, black women tend to have higher rates of hospitalization and higher mortality compared to white women, even after adjustment for chronic kidney disease, time of presentation, insurance and treatment in the first 24 hours.14 In contrast, this study found higher in-hospital mortality in young white women. These contrasting findings may be attributable to the acuity and organ failure in AMI-CS, which may predominate over the comorbid conditions in the evaluation of short-term mortality.3 Regardless, the interaction of age, sex and race are worthy of further careful study in this vulnerable population of critically ill AMI-CS patients.
Limitations
This study has several limitations, despite the HCUP-NIS database’s attempts to mitigate potential errors by using internal and external quality control measures. The ICD-9CM codes for AMI and CS have been previously validated that reduces the inherent errors in the study.46, 47 It is conceivable that increased recognition and subsequent coding of CS could have contributed to the increase in prevalence as noted in our study. Important factors such as the delay in presentation from time of onset of AMI symptoms, timing of CS, reasons for not receiving aggressive medical care, timing of multi-organ failure, and treatment-limiting decisions of organ support could not be reliably identified in this database. It is possible that despite best attempts at mitigating confounding by a multivariable analysis, female sex was a marker of greater illness severity due to residual confounding. Echocardiographic data, angiographic variables, and hemodynamic parameters were unavailable in this database which limits physiological assessments of disease severity. Lastly, spontaneous coronary artery dissection or coronary spasm, which is noted more frequently in young women presenting with AMI, could not be ascertained in this population due to the non-specific coding for this etiology.48
CONCLUSIONS
In young (≤55 years) AMI-CS admissions, there remain significant sex disparities in the management and outcomes. Younger women had higher comorbidity, lower acuity of illness, lower use of coronary angiography and PCI and higher in-hospital mortality. Further quantitative and qualitative research is needed in these vulnerable populations to better understand the underlying reasons for these differences in resource utilization in this high risk population and what can be done to improve the outcome.
Supplementary Material
CLINICAL PERSPECTIVE.
What is new?
Younger women with acute myocardial infarction-cardiogenic shock received less frequent coronary angiography (78.3% vs. 81.4%), early coronary angiography (49.2% vs. 54.1%), PCI (59.2% vs. 64.0%), and MCS (50.3% vs. 59.2%) then young men (all p<0.001).
Female sex was an independent predictor of higher in-hospital mortality (23.0% vs. 21.7%; adjusted odds ratio 1.11 [95% confidence interval 1.07–1.16]; p<0.001) in young admissions with acute myocardial infarction-cardiogenic shock.
What are the clinical implications?
Younger women had lower acuity of illness, lower use of coronary angiography and percutaneous coronary intervention and higher in-hospital mortality. Whether decreases in invasive strategies has a causal relationship with outcome needs further study.
ACKNOWLEDGEMENTS
SOURCES OF FUNDING
Dr. Saraschandra Vallabhajosyula is supported by the Clinical and Translational Science Award (CTSA) Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.
ABBREVIATIONS
- AMI
acute myocardial infarction
- CABG
coronary artery bypass grafting
- CI
confidence interval
- CS
cardiogenic shock
- DNR
do-not-resuscitate
- HCUP
Healthcare Cost and Utilization Project
- ICD-9CM
International Classification of Diseases-9 Clinical Modification
- ICD-10CM
International Classification of Diseases-10 Clinical Modification
- MCS
mechanical circulatory support
- NIS
National/Nationwide Inpatient Sample
- OR
odds ratio
- PCI
percutaneous coronary intervention
Footnotes
DISCLOSURES
All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
REFERENCES
- 1.Vallabhajosyula S, Dunlay SM, Barsness GW, Rihal CS, Holmes DR Jr., and Prasad A. Hospital-level disparities in the outcomes of acute myocardial infarction with cardiogenic shock. Am J Cardiol. 2019;124:491–498. [DOI] [PubMed] [Google Scholar]
- 2.Vallabhajosyula S, Dunlay SM, Kashani K, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Jaffe AS and Barsness GW. Temporal trends and outcomes of prolonged invasive mechanical ventilation and tracheostomy use in acute myocardial infarction with cardiogenic shock in the United States. Int J Cardiol. 2019;285:6–10. [DOI] [PubMed] [Google Scholar]
- 3.Vallabhajosyula S, Dunlay SM, Prasad A, Kashani K, Sakhuja A, Gersh BJ, Jaffe AS, Holmes DR Jr., and Barsness GW. Acute noncardiac organ failure in acute myocardial infarction with cardiogenic shock. J Am Coll Cardiol. 2019;73:1781–1791. [DOI] [PubMed] [Google Scholar]
- 4.Vallabhajosyula S, Kumar V, Vallabhajosyula S, Subramaniam AV, Patlolla SH, Verghese D, Ya’Qoub L, Stulak JM, Sandhu GS, Prasad A, Holmes DR Jr, . and Barsness GW. Acute myocardial infarction-cardiogenic shock in patients with prior coronary artery bypass grafting: A 16-year national cohort analysis of temporal trends, management and outcomes. Int J Cardiol. 2020; 310:9–15. [DOI] [PubMed] [Google Scholar]
- 5.Vallabhajosyula S, Patlolla SH, Dunlay SM, Prasad A, Bell MR, Jaffe AS, Gersh BJ, Rihal CS, Holmes DR Jr, and Barsness GW. Regional variation in the management and outcomes of acute myocardial infarction with cardiogenic shock in the United States. Circ Heart Fail. 2020;13:e006661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Vallabhajosyula S, Prasad A, Dunlay SM, Murphree DH Jr., Ingram C, Mueller PS, Gersh BJ, Holmes DR Jr., and Barsness GW. Utilization of palliative care for cardiogenic shock complicating acute myocardial infarction: A 15-year national perspective on trends, disparities, predictors, and outcomes. J Am Heart Assoc. 2019;8:e011954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998–3002. [DOI] [PubMed] [Google Scholar]
- 8.Vallabhajosyula S, Dunlay SM, Barsness GW, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Gersh BJ, Jaffe AS and Kashani K. Temporal trends, predictors, and outcomes of acute kidney injury and hemodialysis use in acute myocardial infarction-related cardiogenic shock. PLoS One. 2019;14:e0222894. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Vallabhajosyula S, Kashani K, Dunlay SM, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Gersh BJ, Jaffe AS and Barsness GW. Acute respiratory failure and mechanical ventilation in cardiogenic shock complicating acute myocardial infarction in the USA, 2000–2014. Ann Intensive Care. 2019;9:96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Vallabhajosyula S, Dunlay SM, Murphree DH Jr., Barsness GW, Sandhu GS, Lerman A and Prasad A. Cardiogenic shock in takotsubo cardiomyopathy versus acute myocardial infarction: an 8-year national perspective on clinical characteristics, management, and outcomes. JACC Heart Fail. 2019;7:469–476. [DOI] [PubMed] [Google Scholar]
- 11.Vallabhajosyula S, Vallabhajosyula S, Dunlay SM, Hayes SN, Best PJM, Brenes-Salazar JA, Lerman A, Gersh BJ, Jaffe AS, Bell MR, Holmes DR Jr., and Barsness GW. Sex and gender disparities in the management and outcomes of acute myocardial infarction-cardiogenic shock in older adults. Mayo Clin Proc. 2020:In press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Vallabhajosyula S, Ya’Qoub L, Dunlay SM, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Jaffe AS, Gersh BJ and Kashani K. Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock. ESC Heart Fail. 2019;6:874–877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Joseph SM, Brisco MA, Colvin M, Grady KL, Walsh MN and Cook JL. Women with cardiogenic shock derive greater benefit from early mechanical circulatory support: an update from the cVAD Registry. J Interv Cardiol. 2016;29:248–56. [DOI] [PubMed] [Google Scholar]
- 14.Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE and Wenger NK. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133:916–47. [DOI] [PubMed] [Google Scholar]
- 15.Rao U, Buchanan GL and Hoye A. Outcomes after percutaneous coronary intervention in women: are there differences when compared with men? Interv Cardiol. 2019;14:70–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gupta A, Barrabes JA, Strait K, Bueno H, Porta-Sanchez A, Acosta-Velez JG, Lidon RM, Spatz E, Geda M, Dreyer RP, Lorenze N, Lichtman J, D’Onofrio G and Krumholz HM. Sex differences in timeliness of reperfusion in young patients with ST-segment-elevation myocardial infarction by initial electrocardiographic characteristics. J Am Heart Assoc. 2018;7:e007021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Lichtman JH, Leifheit EC, Safdar B, Bao H, Krumholz HM, Lorenze NP, Daneshvar M, Spertus JA and D’Onofrio G. Sex differences in the presentation and perception of symptoms among young patients with myocardial infarction: evidence from the VIRGO study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients). Circulation. 2018;137:781–790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Epps KC, Holper EM, Selzer F, Vlachos HA, Gualano SK, Abbott JD, Jacobs AK, Marroquin OC, Naidu SS, Groeneveld PW and Wilensky RL. Sex differences in outcomes following percutaneous coronary intervention according to age. Circ Cardiovasc Qual Outcomes. 2016;9:S16–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bandyopadhyay D, Chakraborty S, Amgai B, Patel N, Hajra A, Heise L, Sud K, Ghosh RK, Herzog E, Aronow WS, Fonarow GC and Lavie CJ. Acute myocardial infarction in the young - national trend analysis with gender-based difference in outcomes. Int J Cardiol. 2020;301:21–28. [DOI] [PubMed] [Google Scholar]
- 20.Gulati R, Behfar A, Narula J, Kanwar A, Lerman A, Cooper L and Singh M. Acute myocardial infarction in young individuals. Mayo Clin Proc. 2020;95:136–156. [DOI] [PubMed] [Google Scholar]
- 21.Fengler K, Fuernau G, Desch S, Eitel I, Neumann FJ, Olbrich HG, de Waha A, de Waha S, Richardt G, Hennersdorf M, Empen K, Hambrecht R, Fuhrmann J, Bohm M, Poess J, Strasser R, Schneider S, Schuler G, Werdan K, Zeymer U and Thiele H. Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol. 2015;104:71–8. [DOI] [PubMed] [Google Scholar]
- 22.Wong SC, Sleeper LA, Monrad ES, Menegus MA, Palazzo A, Dzavik V, Jacobs A, Jiang X and Hochman JS. Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry. J Am Coll Cardiol. 2001;38:1395–401. [DOI] [PubMed] [Google Scholar]
- 23.Redfors B, Angeras O, Ramunddal T, Petursson P, Haraldsson I, Dworeck C, Odenstedt J, Ioaness D, Ravn-Fischer A, Wellin P, Sjoland H, Tokgozoglu L, Tygesen H, Frick E, Roupe R, Albertsson P and Omerovic E. Trends in gender differences in cardiac care and outcome after acute myocardial infarction in western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). J Am Heart Assoc. 2015;4:e001995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Introduction to the HCUP Nationwide Inpatient Sample 2009. http://www.hcup-us.ahrq.gov/db/nation/nis/NIS_2009_INTRODUCTION.pdf. Accessed Jan 18, 2015.
- 25.Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE and Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–9. [DOI] [PubMed] [Google Scholar]
- 26.Egbe AC, Vallabhajosyula S, Vojjini R, Banala K, Najam M, Faizee F, Khalil F, Ullah MW and Deshmukh AJ. Prevalence and in-hospital mortality during arrhythmia-related admissions in adults with tetralogy of Fallot. Int J Cardiol. 2019;297:49–54. [DOI] [PubMed] [Google Scholar]
- 27.Vallabhajosyula S, Arora S, Lahewala S, Kumar V, Shantha GPS, Jentzer JC, Stulak JM, Gersh BJ, Gulati R, Rihal CS, Prasad A and Deshmukh AJ. Temporary mechanical circulatory support for refractory cardiogenic shock before left ventricular assist device surgery. J Am Heart Assoc. 2018;7:e010193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Vallabhajosyula S, Barsness GW and Vallabhajosyula S. Multidisciplinary teams for cardiogenic shock. Aging (Albany NY). 2019;11:4774–4776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Vallabhajosyula S, Deshmukh AJ, Kashani K, Prasad A and Sakhuja A. Tako-tsubo cardiomyopathy in severe sepsis: nationwide trends, predictors, and outcomes. J Am Heart Assoc. 2018;7:e009160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Vallabhajosyula S, O’Horo JC, Antharam P, Ananthaneni S, Vallabhajosyula S, Stulak JM, Dunlay SM, Holmes DR Jr., and Barsness GW. Venoarterial extracorporeal membrane oxygenation with concomitant impella versus venoarterial extracorporeal membrane oxygenation for cardiogenic shock. ASAIO J. 2020;66(5):497–503. [DOI] [PubMed] [Google Scholar]
- 31.Vallabhajosyula S, Prasad A, Gulati R and Barsness GW. Contemporary prevalence, trends, and outcomes of coronary chronic total occlusions in acute myocardial infarction with cardiogenic shock. Int J Cardiol Heart Vasc. 2019;24:100414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Vallabhajosyula S, Prasad A, Bell MR, Sandhu GS, Eleid MF, Dunlay SM, Schears GJ, Stulak JM, Singh M, Gersh BJ, Jaffe AS, Holmes DR Jr., Rihal CS and Barsness GW. Extracorporeal membrane oxygenation use in acute myocardial infarction in the United States, 2000 to 2014. Circ Heart Fail. 2019;12:e005929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Vallabhajosyula S, Prasad A, Sandhu GS, Bell MR, Gulati R, Eleid MF, Best PJM, Gersh BJ, Singh M, Lerman A, Holmes DR Jr., Rihal CS and Barsness GW. Mechanical circulatory support-assisted early percutaneous coronary intervention in acute myocardial infarction with cardiogenic shock: 10-year national temporal trends, predictors and outcomes. EuroIntervention. 2019; doi: 10.4244/EIJ-D-19-00226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Subramaniam AV, Barsness GW, Vallabhajosyula S and Vallabhajosyula S. Complications of temporary percutaneous mechanical circulatory support for cardiogenic shock: an appraisal of contemporary literature. Cardiol Ther. 2019;8:211–228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Vallabhajosyula S, El Hajj SC, Bell MR, Prasad A, Lerman A, Rihal CS, Holmes DR Jr., and Barsness GW. Intravascular ultrasound, optical coherence tomography, and fractional flow reserve use in acute myocardial infarction. Catheter Cardiovasc Interv. 2019; doi: 10.1002/ccd.28543. [DOI] [PubMed] [Google Scholar]
- 36.Vallabhajosyula S, Vallabhajosyula S, Bell MR, Prasad A, Singh M, White RD, Jaffe AS, Holmes DR Jr., and Jentzer JC. Early vs. delayed in-hospital cardiac arrest complicating ST-elevation myocardial infarction receiving primary percutaneous coronary intervention. Resuscitation. 2020;148:242–250. [DOI] [PubMed] [Google Scholar]
- 37.Vallabhajosyula S, Arora S, Sakhuja A, Lahewala S, Kumar V, Shantha GPS, Egbe AC, Stulak JM, Gersh BJ, Gulati R, Rihal CS, Prasad A and Deshmukh AJ. Trends, predictors, and outcomes of temporary mechanical circulatory support for postcardiac surgery cardiogenic shock. Am J Cardiol. 2019;123:489–497. [DOI] [PubMed] [Google Scholar]
- 38.Vallabhajosyula S, Jentzer JC and Zack CJ. Cardiac arrest definition using administrative codes and outcomes in acute myocardial infarction. Mayo Clin Proc. 2020;95:611–613. [DOI] [PubMed] [Google Scholar]
- 39.Vallabhajosyula S, Vallabhajosyula S, Bell MR, Prasad A, Singh M, White RD, Jaffe AS, Holmes DR Jr., and Jentzer JC. Early vs. delayed in-hospital cardiac arrest complicating ST-elevation myocardial infarction receiving primary percutaneous coronary intervention. Resuscitation. 2020;148:242–250. [DOI] [PubMed] [Google Scholar]
- 40.Khera R and Krumholz HM. With great power comes great responsibility: big data research from the National Inpatient Sample. Circ Cardiovasc Qual Outcomes. 2017;10:e003846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Khera R, Angraal S, Couch T, Welsh JW, Nallamothu BK, Girotra S, Chan PS and Krumholz HM. Adherence to Methodological Standards in Research Using the National Inpatient Sample. JAMA. 2017;318:2011–2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Rubini Gimenez M, Zeymer U, Desch S, de Waha-Thiele S, Ouarrak T, Poess J, Meyer-Saraei R, Schneider S, Fuernau G, Stepinska J, Huber K, Windecker S, Montalescot G, Savonitto S, Jeger RV and Thiele H. Sex-specific management in patients with acute myocardial infarction and cardiogenic shock: a substudy of the CULPRIT-SHOCK trial. Circ Cardiovasc Interv. 2020;13:e008537. [DOI] [PubMed] [Google Scholar]
- 43.Raphael CE, Singh M, Bell M, Crusan D, Lennon RJ, Lerman A, Prasad A, Rihal CS, Gersh BJ and Gulati R. Sex differences in long-term cause-specific mortality after percutaneous coronary intervention: temporal trends and mechanisms. Circ Cardiovasc Interv. 2018;11:e006062. [DOI] [PubMed] [Google Scholar]
- 44.Gupta A, Wang Y, Spertus JA, Geda M, Lorenze N, Nkonde-Price C, D’Onofrio G, Lichtman JH and Krumholz HM. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol. 2014;64:337–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Palmeri ST, Lowe AM, Sleeper LA, Saucedo JF, Desvigne-Nickens P and Hochman JS. Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction. Am J Cardiol. 2005;96:1042–9. [DOI] [PubMed] [Google Scholar]
- 46.Coloma PM, Valkhoff VE, Mazzaglia G, Nielsson MS, Pedersen L, Molokhia M, Mosseveld M, Morabito P, Schuemie MJ, van der Lei J, Sturkenboom M and Trifiro G. Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries. BMJ Open. 2013;3:e002862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Lambert L, Blais C, Hamel D, Brown K, Rinfret S, Cartier R, Giguere M, Carroll C, Beauchamp C and Bogaty P. Evaluation of care and surveillance of cardiovascular disease: can we trust medico-administrative hospital data? Can J Cardiol. 2012;28:162–8. [DOI] [PubMed] [Google Scholar]
- 48.Masoomi R, Patel NV and Gupta K. The National Inpatient Sample is not an appropriate database to assess the incidence of spontaneous coronary artery dissection. JACC Cardiovasc Interv. 2018;11:814–815. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
